Bio-Techne (TECH) Form 4 BIO-TECHNE / James Hippel ownership change

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:	3235-0287
Estimated average burden
hours per response:	0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Hippel James

(Last) (First) (Middle)

614 MCKINLEY PLACE NE

(Street)

MINNEAPOLIS MN 55413

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
BIO-TECHNE Corp [ TECH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
CFO

3. Date of Earliest Transaction (Month/Day/Year)
07/23/2024

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	07/23/2024		M		35,000	A	$31.26	107,284(1)	D
Common Stock	07/23/2024		F		24,282	D	$77.77	83,002	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Options (Right to Buy)	$31.26	07/23/2024		M			35,000	(2)	08/09/2024	Common Stock	35,000	$0	106,867	D
Stock Options (Right to Buy)	$44.33							(2)	08/08/2025	Common Stock	168,620		168,620	D
Stock Options (Right to Buy)	$47.6							(2)	08/07/2026	Common Stock	186,068		186,068	D
Stock Options (Right to Buy)	$66.97							(2)	08/05/2027	Common Stock	90,740		90,740	D
Stock Options (Right to Buy)	$66.97							(3)	08/05/2027	Common Stock	76,588		76,588	D
Restricted Stock Units	(4)							(5)	(5)	Common Stock	7,780		7,780	D
Performance Stock Options (Right to Buy)	$120.46							(5)	08/06/2028	Common Stock	30,400		30,400	D
Stock Options (Right to Buy)	$120.46							(6)	08/06/2028	Common Stock	40,536		40,536	D
Restricted Stock Units	(4)							(7)	(7)	Common Stock	10,912		10,912	D
Performance Stock Options (Right to Buy)	$94.52							(7)	08/15/2029	Common Stock	33,916		33,916	D
Stock Options (Right to Buy)	$94.52							(8)	08/15/2029	Common Stock	45,220		45,220	D
Restricted Stock Units	(4)							(9)	(9)	Common Stock	13,865		13,865	D
Performance Stock Options (Right to Buy)	$84.61							(9)	08/15/2030	Common Stock	37,314		37,314	D
Stock Options (Right to Buy)	$84.61							(10)	08/15/2030	Common Stock	45,923		45,923	D
Restricted Stock Units	(4)							(11)	(11)	Common Stock	26,318		26,318	D

Explanation of Responses:

1. The Reporting Person's direct ownership has been increased by 400 shares pursuant to a clerical error in a previous filing.

2. Fully exercisable.

3. Options to purchase 19,147 shares vest on each of 8/5/2021, 8/5/2022, 8/5/2023 and 8/5/2024.

4. Each restricted stock unit represents a contingent right to receive one share of Bio-Techne Corporation common stock.

5. Vests in full or in part on 8/6/2024 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).

6. Options to purchase 10,134 shares vest on each of 8/6/2022, 8/6/2023, 8/6/2024 and 8/6/2025.

7. Vests in full or in part on 8/15/2025 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).

8. Options to purchase 11,305 shares vest on each of 8/15/2023, 8/15/2024, 8/15/2025 and 8/15/2026.

9. Vests in full or in part on 8/15/2026 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).

10. Options to purchase 11,481 shares vest on each of 8/15/2024, 8/15/2025 and 8/15/2027, and options to purchase 11,480 shares vest on 8/15/2026.

11. 13,159 restricted stock units vest on each of 11/1/2024 and 11/1/2025.

	/s/ Andrew Nick as Attorney-in-Fact for James Hippel pursuant to Power of Attorney previously filed	07/25/2024
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.